Mechanisms of symptom generation in patients with lactose intolerance: lessons learned from validated symptom assessment during lactose breath tests

BACKGROUND: Lactose intolerance is a common cause of functional gastrointestinal symptoms. Traditional diagnostic strategies primarily focus on detecting malabsorption despite symptoms often occurring without it. OBJECTIVES: This study examined the role of malabsorption and nonmalabsorptive mechanisms in the development of symptoms in patients with lactose intolerance. DESIGN: We analyzed 1015 patients undergoing standardized 50-g lactose hydrogen (H2) breath testing with simultaneous symptom assessment using the adult Carbohydrate Perception Questionnaire. Malabsorption was defined as an H2 increase greater than 20 ppm, and intolerance as a ≥ 20- and 35-mm increase in symptom scores. Breath test parameters and symptom patterns were compared across four groups: symptomatic malabsorbers (S+/M+), asymptomatic malabsorbers (S-/M+), symptomatic nonmalabsorbers or symptomatic absorbers (S+/M-), and asymptomatic nonmalabsorbers or asymptomatic absorbers (S-/M-). Linear and multiple regressions and receiver operating characteristic (ROC) analyses evaluated associations between H2 kinetics and symptoms. RESULTS: Symptoms occurred frequently both with and without malabsorption: 267 (S+/M+) and 236 (S+/M-). S+/M+ patients showed higher maximal H2 (98 vs. 59 ppm), larger area under the ROC curve (AUC) H2, and faster H2 accumulation than S-/M+ (all P < 0.001). Symptom burdens were higher in S+/M+ than S+/M- (133 vs. 72 mm; P < 0.001). However, H2 increases explained only 22% of symptom variance. In regression models, flatulence, pain, and diarrhea independently predicted malabsorption, while bloating and nausea did not. ROC performance was modest for both H2 (AUC: 0.66) and symptoms (AUC: 0.70). CONCLUSION: Lactose-induced symptoms arise through two partially independent mechanisms: a malabsorptive colonic fermentation pathway and a nonmalabsorptive pathway. Breath testing alone is insufficient to identify clinically relevant lactose intolerance; integrating physiological and symptom-based measures provides a more accurate mechanistic understanding.